Obrindatamab, CAS 2069959-72-2

Product Description: Obrindatamab is a humanized anti-B7-H3/CD3 bispecific antibody. Obrindatamab binds to B7-H3 and CD3, thereby mediating redirected cytotoxic T-lymphocyte (CTL) activity against B7-H3-expressing cancer cells. Obrindatamab can be used in research of cancer[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Paul M, et, al. MGD009, a B7-H3 x CD3 Bispecific Dual-Affinity Re-Targeting (DART®) Molecule Directing T Cells to Solid Tumors.

CAS Number: 2069959-72-2

Molecular Weight: N/A

Compound Purity: 99.58

Research Area: Cancer

Solubility: 10 mM in DMSO

Target: CD3

• Artikelnummer: MEXHY-P99762-5
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P99762-5
• Verpackungseinheit: 5 mg
• Mengeneinheit: STK
• Konjugat: Unconjugated